OPM Biosciences Launches Integrated Cell Culture Media-to-Manufacturing Platform for Biosimilar Development
New portfolio combines high-performance cell culture media, molecule-specific CQA optimization, and integrated CDMO capabilities to help biosimilar developers accelerate the path to analytical similarity and improve process economics. PLEASANTON, Calif. — OPM Biosciences, a cell culture media and bioprocess solutions company, today announced two new offerings that extend its OPM-CHO™ platform…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
